Literature DB >> 27461989

Are we really tackling the "evidence-based medicine issue" in Alzheimer's disease?

Marco Canevelli1, Giuseppe Bruno2, Nicola Vanacore3, Carlo de Lena2, Matteo Cesari4.   

Abstract

Entities:  

Keywords:  Alzheimer's disease; Evidence-based medicine; External validity; Randomized controlled trials

Mesh：

Year:  2016        PMID： 27461989     DOI： 10.1016/j.ejim.2016.07.009

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  3 in total

1.  External Validity of Randomized Controlled Trials on Alzheimer's Disease: The Biases of Frailty and Biological Aging.

Authors:  Marco Canevelli; Alessandro Trebbastoni; Federica Quarata; Fabrizia D'Antonio; Matteo Cesari; Carlo de Lena; Giuseppe Bruno
Journal:  Front Neurol       Date:  2017-11-27       Impact factor: 4.003

2.  Current practices and factors affecting evidence-based occupational therapy practice for patients with dementia in Japan.

Authors:  Ai Hasegawa; Risa Takashima; Kazuki Yoshida; Daisuke Sawamura; Waka Murata; Shinya Sakai
Journal:  Hong Kong J Occup Ther       Date:  2020-12-22       Impact factor: 0.917

3.  Quantifying the heterogeneity of cognitive functioning in Alzheimer's disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil.

Authors:  Stephen Z Levine; Yair Goldberg; Kazufumi Yoshida; Myrto Samara; Andrea Cipriani; Takeshi Iwatsubo; Stefan Leucht; Toshiaki A Furawaka
Journal:  Eur Psychiatry       Date:  2021-02-15       Impact factor: 5.361
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.